Table 3.
Multivariable Cox proportional hazards analysis of the risk of recurrence.
| Patient characteristics | TCGA-HCC test cohort (n = 53) | Stanford-HCC (n = 198) | ||
|---|---|---|---|---|
| Internal test set | External test set | |||
| Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | |
| Risk score (binarized) | 7.44 (1.60, 34.6) | 0.011 | 2.37 (1.27, 4.43) | 0.00685 |
| AJCC stage grouping | ||||
| > II | 0.30 (0.043, 2.11) | 0.23 | 1.57 (0.63, 3.91) | 0.331 |
| Largest tumor diameter (mm) | ||||
| > 50 | 1.09 (0.33, 3.60) | 0.89 | 1.32 (0.67, 2.60) | 0.425 |
| Histologic grade | ||||
| > Moderately-differentiated | 2.82 (0.98, 8.1) | 0.054 | 1.36 (0.69, 2.69) | 0.377 |
| Microvascular invasion | ||||
| Positive | 1.98 (0.59, 6.64) | 0.27 | 2.84 (1.61, 5.00) | 0.000294 |
| Macrovascular invasion | ||||
| Positive | 3.76 (0.77, 18.4) | 0.10 | 1.42 (0.42, 4.86) | 0.575 |
| Surgical margin | ||||
| Positive | 0.51 (0.079, 3.3) | 0.47 | 4.45 (0.84, 23.7) | 0.0797 |
| Fibrosis stage | ||||
| > 2 | 0.80 (0.20, 3.1) | 0.74 | 0.50 (0.28, 0.90) | 0.0217 |
CI, confidence interval.